9W1N: Human SLC37A4 ER-membrane glucose-6-phosphate/phosphate antiporter, in its apo, lumen-facing conformation
From Proteopedia
(Difference between revisions)
(New page: ==Your Heading Here (maybe something like 'Structure')== <StructureSection load='9w1n' size='340' side='right' caption='Caption for this structure' scene=''> This is a default text for you...) |
|||
| Line 1: | Line 1: | ||
| - | == | + | ==Structure== |
<StructureSection load='9w1n' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='9w1n' size='340' side='right' caption='Caption for this structure' scene=''> | ||
This is a default text for your page '''Rhea Sachin Raodeo/Sandbox 1'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | This is a default text for your page '''Rhea Sachin Raodeo/Sandbox 1'''. Click above on '''edit this page''' to modify. Be careful with the < and > signs. | ||
| Line 8: | Line 8: | ||
9W1N captures SLC37A4 in its lumen-facing, substrate-free conformation, representing the starting point of the G6P/Pi exchange cycle. | 9W1N captures SLC37A4 in its lumen-facing, substrate-free conformation, representing the starting point of the G6P/Pi exchange cycle. | ||
The central cavity is open toward the ER lumen and sealed on the cytosolic side, consistent with a transporter ready to release Pi or to bind luminal factors. | The central cavity is open toward the ER lumen and sealed on the cytosolic side, consistent with a transporter ready to release Pi or to bind luminal factors. | ||
| + | |||
This state provides the template for how the transporter organises a pre-formed phosphate pocket before substrate binds. | This state provides the template for how the transporter organises a pre-formed phosphate pocket before substrate binds. | ||
| Line 13: | Line 14: | ||
9W1N reveals the positions of conserved Lys/His residues (K29, K64, H366) forming the phosphate-binding hotspot; many GSD-Ib mutations map directly onto this region. | 9W1N reveals the positions of conserved Lys/His residues (K29, K64, H366) forming the phosphate-binding hotspot; many GSD-Ib mutations map directly onto this region. | ||
| + | |||
The apo structure reveals how even small perturbations of the substrate cavity or cytoplasmic gate can disrupt the correct lumen-open geometry, explaining loss-of-function phenotypes. | The apo structure reveals how even small perturbations of the substrate cavity or cytoplasmic gate can disrupt the correct lumen-open geometry, explaining loss-of-function phenotypes. | ||
| + | |||
Several pathogenic variants cluster at the dimer interface surfaces, clearly visualised in 9W1N. | Several pathogenic variants cluster at the dimer interface surfaces, clearly visualised in 9W1N. | ||
| Line 19: | Line 22: | ||
9W1N is the reference architecture for all other SLC37A4 structures, Pi-bound (9W1O), G6P-bound (9W1P), lateral dimers, and the inhibitor-bound cytosol-open state (9W1R). | 9W1N is the reference architecture for all other SLC37A4 structures, Pi-bound (9W1O), G6P-bound (9W1P), lateral dimers, and the inhibitor-bound cytosol-open state (9W1R). | ||
| - | It defines the resting, lumen-open gate essential for understanding | + | |
| - | + | It defines the resting, lumen-open gate essential for understanding how substrates gain access to the ER-facing cavity, how is antiport asymmetry maintained and which structural elements move during transport. | |
| - | + | ||
| - | + | ||
Serves as a baseline for comparing disease mutations, substrate recognition, and inhibitor locking. | Serves as a baseline for comparing disease mutations, substrate recognition, and inhibitor locking. | ||
== Structural highlights == | == Structural highlights == | ||
| - | State captured: Apo, lumen-facing, antiparallel dimer (C2 symmetry). | + | State captured: Apo, lumen-facing, antiparallel dimer (C2 symmetry). Resolution: ~3.2 Å cryo-EM, allowing accurate visualisation of the central cavity, gates, and conserved charged residues. |
| - | Resolution: ~3.2 Å cryo-EM, allowing accurate visualisation of the central cavity, gates, and conserved charged residues. | + | |
| - | Dimer architecture: | + | Dimer architecture: It has a unique antiparallel packing of the two protomers. The interface is tight but still allows for large-scale rearrangements, as seen in lateral dimers. |
| - | + | ||
| - | The interface is tight but still allows for large-scale rearrangements, as seen in lateral dimers. | + | Cavity features are that it has a positively charged, pre-shaped phosphate pocket despite the absence of a ligand. The residues K29, K64, M145, and H366 are positioned for immediate substrate coordination. |
| - | Cavity features | + | |
| - | + | The cytosolic gate has closed—TM helices pack to block access. The luminal gate is open, showing a clear solvent-accessible path. This represents the lumen-access state in the alternating-access cycle. | |
| - | The residues K29, K64, M145, and H366 are positioned for immediate substrate coordination. | + | |
| - | + | It also serves as the structural endpoint opposite the cytosol-open inhibitor-bound structure (9W1R). | |
| - | + | ||
| - | The luminal gate is open, showing a clear solvent-accessible path. | + | |
| - | + | ||
| - | This represents the lumen-access state in the alternating-access cycle. | + | |
| - | It serves as the structural endpoint opposite the cytosol-open inhibitor-bound structure (9W1R). | + | |
This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | This is a sample scene created with SAT to <scene name="/12/3456/Sample/1">color</scene> by Group, and another to make <scene name="/12/3456/Sample/2">a transparent representation</scene> of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes. | ||
Revision as of 17:13, 30 November 2025
Structure
| |||||||||||
References
Zhou, D., Zhang, Y., Chen, N. et al. Structural basis of G6P/Pi transport and inhibition in SLC37A4. Nat Struct Mol Biol (2025). https://doi.org/10.1038/s41594-025-01711-5
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
